Benelux experience with a combination of tacrolimus and mycophenolate mofetil: 4-year results.
van Hooff
J P
JP
Department of Internal Medicine, University Hospital Maastricht, PO Box 5800, NL-6202 AZ Maastricht, The Netherlands. jho@sint.azm.nl
Squifflet
Jean-Paul
JP
Vanrenterghem
Y
Y
D001530:Belgium; D005260:Female; D005500:Follow-Up Studies; D006085:Graft Survival / Q000502:physiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality; D008189:Luxembourg; D008297:Male; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use*; D015996:Survival Rate; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors; D014019:Tissue Donors / Q000706:statistics & numerical data
D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid; D016559:Tacrolimus